159 related articles for article (PubMed ID: 20716892)
1. [A case of metastatic colorectal cancer suffering from hyperammonemic encephalopathy induced by 5-FU, continuously treated with FOLFOX therapy].
Shoji H; Kuroki M; Hiramoto K; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1583-6. PubMed ID: 20716892
[TBL] [Abstract][Full Text] [Related]
2. [A case of hyperammonemic encephalopathy in a patient with recurrent colon cancer treated with modified FOLFOX6].
Teraishi F; Suzuki T; Nakamoto M; Chikuba A; Nezu M; Shimamura H; Watanabe T; Matsuda T; Takiue T; Chikuba H
Gan To Kagaku Ryoho; 2009 May; 36(5):867-9. PubMed ID: 19461197
[TBL] [Abstract][Full Text] [Related]
3. [A case of metastatic colorectal cancer with hyperammonemic encephalopathy induced by 5-FU in a patient continuously treated with XELOX therapy].
Nakano E; Kuroki M; Kanno N; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2581-4. PubMed ID: 24335375
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Recurrent Hyperammonemic Encephalopathy during Adjuvant Chemotherapy(Modified FOLFOX6)for Colorectal Cancer].
Yoshino Y; Tamura A; Kagami S; Funahashi K
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1665-1668. PubMed ID: 30449860
[TBL] [Abstract][Full Text] [Related]
5. [A case of colon cancer with multiple lung metastases responding completely to FOLFIRI and FOLFOX therapy].
Kume S; Takahashi M; Kubota T; Hirata T; Torigoe Y; Ikeda O; Goto Y
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1809-12. PubMed ID: 20841953
[TBL] [Abstract][Full Text] [Related]
6. [A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].
Nakagawa M; Hamada A; Yoshihara Y; Ishizaka T; Fukushima M; Takahashi N; Sawada R; Mukai J
Gan To Kagaku Ryoho; 2011 Feb; 38(2):317-20. PubMed ID: 21368504
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies.
Ohtani H; Arimoto Y; Nishio K; Kanamiya Y; Oba H; Adachi K; Shintani M; Nakamura R; Yui S
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1769-74. PubMed ID: 18931586
[TBL] [Abstract][Full Text] [Related]
8. [A case of advanced ascending colon cancer, curatively resected after complete response in left supraclavicular and paraaortic lymph nodes and liver metastases to FOLFOX4 therapy].
Furumoto K; Kojima H; Takaya H; Okuno M; Fuji H; Mizuno R; Mori T; Ito D; Kogire M
Gan To Kagaku Ryoho; 2010 Feb; 37(2):323-6. PubMed ID: 20154495
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Consciousness Disturbance Caused by Hyperammonemia during a mFOLFOX6 Regimen for Metastatic Colon Cancer].
Kagawa Y; Kato T; Naito A; Murakami K; Katsura Y; Ohmura Y; Okishiro M; Takeno A; Egawa C; Takeda Y; Tamura S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2160-2. PubMed ID: 26805297
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of hyperammonemic patients treated by chemotherapy for colorectal cancer].
Aihara A; Terasawa M; Furukawa S; Kasai R; Ito T; Ochiai T; Kumagai Y; Iida M; Yamazaki S
Gan To Kagaku Ryoho; 2012 May; 39(5):839-42. PubMed ID: 22584345
[TBL] [Abstract][Full Text] [Related]
11. [A case of hyperammonemia with encephalopathy related to FOLFIRI chemotherapy for advanced colon cancer].
Toyokawa A; Nakajima T; Inui K; Yamashita H; Gon H; Kanemitsu K; Tanaka K; Tsukamoto T; Hamabe Y; Ishida T
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1167-9. PubMed ID: 19620810
[TBL] [Abstract][Full Text] [Related]
12. Leucovorin-induced hypersensitivity reaction.
Damaske A; Ma N; Williams R
J Oncol Pharm Pract; 2012 Mar; 18(1):136-9. PubMed ID: 21248170
[TBL] [Abstract][Full Text] [Related]
13. [A case of hyperammonemic encephalopathy related to 5-FU in an aged patient with recurrent colon cancer treated with FOLFIRI therapy].
Okamura T; Kawachi Y; Nikkuni K; Nishimura A; Makino S; Kawahara M; Kitami C; Hashimoto Y
Gan To Kagaku Ryoho; 2013 May; 40(5):671-3. PubMed ID: 23863598
[TBL] [Abstract][Full Text] [Related]
14. [PSK decreased FOLFOX4-induced peripheral neuropathy and bone marrow suppression in patients with metastatic colorectal cancer].
Shibata M; Shimura T; Nishina Y; Gonda K; Matsuo S; Abe H; Yajima Y; Nakamura I; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2011 May; 38(5):797-801. PubMed ID: 21566440
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
16. [A case of ascending colon cancer with unresectable distant metastases treated by systemic chemotherapy].
Sugimoto K; Tashiro Y; Nagayasu K; Niwa K; Ono S; Ishiyama S; Hata M; Komiyama H; Takahashi M; Yaginuma Y; Kojima Y; Goto M; Tanaka M; Sengoku H; Okuzawa A; Tomiki Y; Sakamoto K
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1167-70. PubMed ID: 20567130
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer.
Spigel DR; Greco FA; Waterhouse D; Shipley D; Lane CM; Vazquez ER; Clark BL; Infante JR; Bendell JC; Burris HA; Hainsworth JD
Clin Adv Hematol Oncol; 2010 Jul; 8(7):480-5, 498. PubMed ID: 20864916
[TBL] [Abstract][Full Text] [Related]
18. [A case of drug-induced lung injury associated with chemotherapy (FOLFOX6, FOLFIRI, Bevacizumab) for an advanced colon cancer].
Komaki C; Hanatate F; Kobayashi K
Gan To Kagaku Ryoho; 2011 Jan; 38(1):113-6. PubMed ID: 21368470
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.
Malkhasyan K; Halene S; Lacy J
Clin Colorectal Cancer; 2015 Mar; 14(1):e9-e12. PubMed ID: 25446051
[No Abstract] [Full Text] [Related]
20. Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.
Angitapalli R; Litwin AM; Kumar PR; Nasser E; Lombardo J; Mashtare T; Wilding GE; Fakih MG
Oncology; 2009; 76(5):363-8. PubMed ID: 19321964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
